News - Page 239 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article ATAI Life Sciences Announces Closing of $125 Million Series C Financing Round

ATAI Life Sciences Announces Closing of $125 Million Series C Financing Round

Post published:November 23, 2020
Post category:Press Release

Read more about the article Novamind Closes Oversubscribed CAD$10 Million Private Placement

Novamind Closes Oversubscribed CAD$10 Million Private Placement

Post published:November 23, 2020
Post category:Press Release

Read more about the article Research Suggests Past Antidepressant Usage Reduces Efficacy of MDMA-Assisted Psychotherapy for PTSD

Research Suggests Past Antidepressant Usage Reduces Efficacy of MDMA-Assisted Psychotherapy for PTSD

Post published:November 23, 2020
Post category:News

Read more about the article BBC Two Programme to Follow Psychedelics vs. Antidepressants Trial

BBC Two Programme to Follow Psychedelics vs. Antidepressants Trial

Post published:November 22, 2020
Post category:News

Read more about the article Red Light Holland and Halo Labs Announce Intention to Enter Oregon Medicinal Psilocybin Market

Red Light Holland and Halo Labs Announce Intention to Enter Oregon Medicinal Psilocybin Market

Post published:November 20, 2020
Post category:Press Release

Read more about the article Psychedelic Bulletin: Non-Palliative Canadian Receives Psilocybin Therapy; Germany Backs Psilocybin Study; MindMed Moves Forward with LSD for ADHD Trial

Psychedelic Bulletin: Non-Palliative Canadian Receives Psilocybin Therapy; Germany Backs Psilocybin Study; MindMed Moves Forward with LSD for ADHD Trial

Post published:November 20, 2020
Post category:Psychedelic Bulletin

Read more about the article Mind Cure Announces Closing of Oversubscribed $3.6 Million Offering

Mind Cure Announces Closing of Oversubscribed $3.6 Million Offering

Post published:November 19, 2020
Post category:Press Release

Read more about the article Nick Milne, Co-founder and CSO at Octarine Bio

Nick Milne, Co-founder and CSO at Octarine Bio

Post published:November 19, 2020
Post category:Interview

Read more about the article Field Trip Health Ltd. and WHOOP announce partnership to measure effect of psychedelic therapies on physiology and mental health

Field Trip Health Ltd. and WHOOP announce partnership to measure effect of psychedelic therapies on physiology and mental health

Post published:November 19, 2020
Post category:Press Release

Read more about the article Psilocybin for Depression Study Approved and Funded by German Government

Psilocybin for Depression Study Approved and Funded by German Government

Post published:November 19, 2020
Post category:Clinical Trials News

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.